Zhejiang East Asia Pharmaceutical Co., Ltd., was founded in 1998, headquartered in Taizhou City, Zhejiang Province, now with more than 1,300 employees, with total assets of RMB 1.3 billion. It has successively obtained titles, such as "national high-tech enterprise", "patent demonstration enterprise in Zhejiang Province", “top ten enterprises in management innovation in Taizhou City" and so on. It also has built a provincial research institute, and provincial enterprise technology center, and has repeatedly assumed the national Torch Program projects. Now, it has applied for more than 30 national invention patents, a world patent, and 18 items have been authorized.
East Asia has built an integrated pharmaceutical base in Zhejiang Sanmen, Zhejiang Linhai, Jiangxi Jiujiang, mainly engaged in the bulk pharmaceutical chemicals and intermediates in the fields, such as cardiovascular, anti-aging dementia, digestive system, diabetic neuropathy, anti-pathogenic microorganisms (including β-lactam antibiotics, carbapenems semi-synthetic antibiotics and synthetic antibacterial, antifungal, antiviral) infection and central nervous system. A number of products of the company have passed the new version of CGMP certification, the European Union (EDQM) certification, the Japanese Ministry of Welfare (PMDA) certification. It has established a long-term relationship with the customers in Europe and the United States, Southeast Asia, and more than 10 countries and regions, and the product sales network extends to more than 50 countries and regions.
East Asia has set up a modern research and development center in Shanghai Zhangjiang International Medical Park, and established a doctorate or master's degree-based research team, specialized in research and development of cutting-edge information and technology, thus providing a platform for the company's sustainably developing market competition.
The company adheres to the principle and policy of "quality responsibility, care for life; sincerity and honesty, dedication to development; healthy mission, escort by science and technology; commitment to society, thanksgiving feedback", insists on the nature of kindness to operate the pharmaceutical company with "source of kindness".
Zhejiang East Asia Pharmaceutical Co., Ltd. Mainly engaged in the production of bulk pharmaceutical chemicals, tablets, granules and capsules, main products are: Ofloxacin, levofloxacin, loratadine hydrochloride, levofloxacin hydrochloride, trimebutine maleate, ketoconazole, terbinafine hydrochloride, tiopronin, levofloxacin lactate, epalrestat, piperazine, ticlazole and so on.
Zhejiang Dongbang Pharmaceutical Co., Ltd. Mainly engaged in the production of pharmaceutical intermediates and bulk pharmaceutical chemicals, main products are: Cefaclor, cefixime, cefdinir, ceftibuten, cefprozil and so on.
Jiangxi Shanyuan Pharmaceutical Co., Ltd. Mainly engaged in the production of pharmaceutical intermediates and bulk pharmaceutical chemicals, main products are AEVTS, MAP, ABPA, faropenem sodium, dimetindene and so on.
Shanghai Youshou Medicine Technology Development Co., Ltd. Have Established a doctorate or master's degree-based research team as East Asia Pharmaceutical research and development center, from the project approval, small test and amplification research and development, production transformation, technical support and other aspects to ensure that the company's products have continued market competitiveness.
